Rizia Bardhan on Muck Rack

Rizia Bardhan

As seen in: Royal Society of Chemistry, Biocompare
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Rizia

Contact Rizia, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Reactive oxygen species driven prodrug-based nanoscale carriers for transformative therapies

|
By Arathy Vasukutty, Rizia Bardhan, In-Kyu Park, Shyam Vasvani
| Royal Society of Chemistry Verified
Reactive oxygen species driven prodrug-based nanoscale carriers for transformative therapies Reactive oxygen species (ROS) drive processes in various pathological conditions serving as an attractive target for therapeutic strategies. This review highlights the development and use of ROS-dependent prodrug-based nanoscale carriers that has transformed many biomedical applications.
Open in Who Shared Issue with article?

Tumor-targeting cell membrane-coated nanorings for magnetic-hyperthermia-induced tumor ablation

|
By Veena Vijayan, Aravindkumar Sundaram, Arathy Vasukutty, Rizia Bardhan
| Royal Society of Chemistry Verified
Tumor-targeting cell membrane-coated nanorings for magnetic-hyperthermia-induced tumor ablation Magnetic hyperthermia has attracted considerable attention for efficient cancer therapy because of its noninvasive nature, deep tissue penetration, and minimal damage to healthy tissues. Herein, we have fused cancer cell membrane fragments with lipids and cloaked them on magnetic nanorings to form targeted Fe nanorings (TF) for tumor-targeted magnetic hyperthermia-induced tumor ablation.
Open in Who Shared View Duplicates (2) Issue with article?

BioLegend PD-L1 Antibody Works Well

|
By Rizia Bardhan
| Biocompare Verified
Wednesday, July 31, 2019 Tweet Email Chemical and Biomolecular Engineering Vanderbilt University Principal Investigator Company: BioLegend Product Name: Alexa Fluor 594 anti-human CD274 (B7-H1, PD-L1) Catalog Number: 329742 Clone Number: 29E.2A3 Info:Supplier Page View Product SpecsView Product Browse Similar Products: CD274 Antibodies We have used BioLegend antiPD-L1 antibody against mouse xenografts with human cell lines and this product yielded the absolute best result.
Open in Who Shared Issue with article?
See all 4 articles
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified